ArticleClinical and experimental immunology1994

Follow up of soluble IL-2 receptor level in metastatic malignant melanoma patients treated by chemoimmunotherapy.

C Soubrane et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.